P445: A SYSTEMS-BASED APPROACH TO UNVEIL DRUG RESISTANCE IN FLT3-ITD AML
Francesca Sacco(Università Cattolica del Sacro Cuore), Monia Pugliese, Felix Klingelhuber(Deutsches Diabetes-Zentrum e.V.), Sara Latini(University of Rome Tor Vergata), Livia Perfetto(Sapienza University of Rome), Giorgia Massacci(University of Rome Tor Vergata), Natalie Krahmer(Helmholtz Zentrum München), V Rezelj Veronica, Valeria Bica(University of Rome Tor Vergata), Martin Böttcher(Otto-von-Guericke-Universität Magdeburg), Thomas Fischer(University Hospital Magdeburg), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg)
Cited by 0
Related Papers
Rap1b is required for normal platelet function and hemostasis in mice
|Journal of Clinical Investigation|2005|307
Advancements and challenges in CAR T cell therapy in autoimmune diseases
|Nature Reviews Rheumatology|2024|203
Anti-CD19 CAR T cells for refractory myasthenia gravis
|The Lancet Neurology|2023|147